THE-THINGS-INDUSTRIES
19.9.2023 16:01:33 CEST | Business Wire | Press release
The Things Industries, a global leader in LoRaWAN® Internet of Things (IoT) solutions, has announced 1.5 million devices connected to its robust network server infrastructure, The Things Stack, marking a new milestone in its journey towards operational excellence and product leadership in the LoRaWAN ecosystem. This and more announcements are being celebrated during the flagship event - The Things Conference, organized by The Things Industries.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230919065625/en/
The Things Industries has reached 1.5 million connected devices to its LoRaWAN Network Server (Graphic: Business Wire)
The company has emerged as a product leader and is widely respected for its operational excellence, uptime, and product completeness. Among its clients and partners are numerous Fortune 500 companies, utility companies, IoT product scale-ups, and a diverse range of system integrators.
This achievement underscores the company's commitment to product leadership and operational excellence in the market of LoRaWAN solution management software, and the ability to scale IoT projects for The Things Industries’ customers and partners. The Things Industries’ LoRaWAN platform is a global product that can be used in every industry vertical.
The recent report by Beecham Research validates the continued growth of LoRaWAN and the adoption across the world. As a global leader in the market of LoRaWAN network management software providers, The Things Industries validates these findings by seeing wide range adoption of the standard on its platform.
The Things Industries serve the market with its leading platform, The Things Stack Cloud, a managed LoRaWAN network server with advanced features and cloud capability that provides industry-leading uptimes with unlimited scalability. With the cloud capability, free and seamless upgrades come included.
The Things Conference, the company's flagship user event, will showcase the broad adoption and usage of the LoRaWAN standard and The Things Stack Cloud platform. The conference will feature over 100 device manufacturers, 110 speakers sharing their IoT experiences, and more than 60 concrete solutions with detailed business cases will be showcased. The Things Conference takes place on 21 and 22 September 2023 from 9 AM to 5 PM Central European Summer Time. The event will be streamed live worldwide.
Wienke Giezeman, CEO of The Things Industries, commented, "The Things Conference is a gathering where we celebrate hard-won successes in the LoRaWAN user space. IoT is a challenging field, and the level of innovation on display is growing every year. I anticipate engaging with the 1,000+ IoT innovators at our event."
About The Things Industries
Founded in 2015, The Things Industries is a leading provider of LoRaWAN IoT solutions, designed to offer secure and efficient connectivity. With a focus on driving efficiency and sustainability, the company estimates that its platform contributes to over $1 billion in efficiency gains for its customers.
For those interested in building IoT solutions based on LoRaWAN, The Things Industries offers a use case selector for product and service recommendations. To get started with the secure LoRaWAN Network Server, visit https://www.thethingsindustries.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230919065625/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 13:00:00 CEST | Press release
Randomized controlled trial will evaluate both symptom progression and underlying biology Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early
Unpack ’26 sommerrejsetrends: Flere vælger indenlandske rejser, når de tænker mere bevidst over deres rejsevalg21.5.2026 12:35:00 CEST | Pressemeddelelse
Rejsebranchens førende databrevne trendrapport lancerer sin første sommerudgave nogensinde – Unpack ’26 Summer: The Trends in Travel I dag har Hotels.com udgivet Unpack ’26 Summer: The Trends in Travel, den nyeste udgave af virksomhedens førende trendrapport i rejsebranchen, som viser, hvordan rejseadfærd former sommerens rejsevalg. Efterspørgslen på indenlandske rejser præger sommerens ferieplanlægning. Interessen på sociale medier for indenlandske ferier er globalt steget med 77% sammenlignet med sidste år, og 44% af danske rejsende planlægger en indenlandsk rejse denne sommer*. Fra store sportsbegivenheder og koncerter til rejser inspireret af film og tv bygger Unpack ’26 Summer på indsigter fra den årlige hovedrapport Unpack ’26: The Trends in Travel™ for at fremhæve, hvor rejsende tager hen denne sommer. HHver tendens bygger på førstehåndsdata fra Hotels.com® kombineret med indsigter fra rejsende og overvågning af sociale medier. “Denne sommer bliver der stadig rejst – men på nye
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend21.5.2026 12:30:00 CEST | Press release
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Company’s previously declared special cash dividend. The Company previously announced a special cash dividend of US$55.00 per common share, payable to valid holders of the Company’s common shares as of the close of business on May 23, 2025 ET. The Company previously informed shareholders that completed instruction materials were to be submitted prior to December 31, 2025 in order to facilitate receipt of the dividend. The Company has now extended that submission deadline to June 30, 2026. Shareholders and nominee brokers that have not yet submitted their instruction materials are reminded to do so on or before June 30, 2026 in order to facilitate payment of the dividend. If you have any questions regarding the process you need to un
Cognite and ABB Collaborate to Integrate Agentic AI into Industrial Applications to Deliver Faster Workflows21.5.2026 12:00:00 CEST | Press release
Aker BP joins as the first customer to scale agent-to-agent operations through a new generation of industrial agentic workflow applications Cognite, the leader in Industrial AI, today announced a collaboration with ABB to assess how advanced industrial AI and data capabilities can be integrated to solve key use cases in the energy sector. By adding an agentic layer to established industrial applications, including ABB Ability™ SafetyInsight™ and ABB Ability™ AlarmInsight™, using the Cognite Industrial AI and Data platform, the collaboration aims to enable "agent-to-agent" orchestration. Leading energy producer Aker BP has signed on as the first customer to implement this new generation of intelligent offerings as part of its strategy to further increase its current production efficiency of 96% and achieve a production growth target of 525,000 barrels of oil equivalent per day by 2028. Transforming Data into Actionable Business Value By breaking down traditional data silos and shifting
BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts21.5.2026 12:00:00 CEST | Press release
Long-term and real-world evidence reinforce BRUKINSA as the foundation of CLL treatmentThree oral presentations at ASCO highlight rapid acceleration of BeOne’s solid tumor pipeline BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that more than 60 abstracts across hematologic malignancies and solid tumors have been accepted for presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (May 29–June 2, Chicago) and the 2026 European Hematology Association (EHA) Congress (June 11–14, Stockholm). Continuing to raise the bar in CLL At ASCO and EHA 2026, BeOne will showcase its hematology leadership with data spanning foundational therapies and next-generation innovation across CLL, mantle cell lymphoma and other B-cell malignancies. The data emphasize impressive long-term outcomes, durability across patient populations, and a disciplined approach to advancing future regimens. Collectively, these data undersco
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom